135 related articles for article (PubMed ID: 10545644)
1. Steroid treatment in young MRL.MpJ-Fas(lpr) autoimmune mice prevents cochlear dysfunction.
Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
Hear Res; 1999 Nov; 137(1-2):167-73. PubMed ID: 10545644
[TBL] [Abstract][Full Text] [Related]
2. Steroid treatment improves cochlear function in the MRL.MpJ-Fas(lpr) autoimmune mouse.
Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
Hear Res; 1999 Nov; 137(1-2):160-6. PubMed ID: 10545643
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice.
Trune DR; Kempton JB; Kessi M
Laryngoscope; 2000 Nov; 110(11):1902-6. PubMed ID: 11081607
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Fas(lpr) autoimmune mice.
Trune DR; Kempton JB
Hear Res; 2001 May; 155(1-2):9-20. PubMed ID: 11335072
[TBL] [Abstract][Full Text] [Related]
5. Steroid-responsive cochlear dysfunction in the MRL/lpr autoimmune mouse.
Wobig RJ; Kempton Jb; Trune DR
Otolaryngol Head Neck Surg; 1999 Oct; 121(4):344-7. PubMed ID: 10504585
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
Trune DR; Kempton JB; Gross ND
Hear Res; 2006 Feb; 212(1-2):22-32. PubMed ID: 16307853
[TBL] [Abstract][Full Text] [Related]
7. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
[TBL] [Abstract][Full Text] [Related]
8. Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.
Trune DR; Kempton JB
Audiol Neurootol; 2009; 14(6):423-31. PubMed ID: 19923812
[TBL] [Abstract][Full Text] [Related]
9. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice.
Trune DR; Kempton JB; Harrison AR; Wobig JL
Hear Res; 2007 Apr; 226(1-2):209-17. PubMed ID: 17098384
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice.
Gross ND; Kempton JB; Trune DR
Laryngoscope; 2002 Feb; 112(2):298-303. PubMed ID: 11889387
[TBL] [Abstract][Full Text] [Related]
12. Low dose combination steroids control autoimmune mouse hearing loss.
Trune DR; Kempton JB
J Neuroimmunol; 2010 Dec; 229(1-2):140-5. PubMed ID: 20800906
[TBL] [Abstract][Full Text] [Related]
13. Female MRL.MpJ-Fas(lpr) autoimmune mice have greater hearing loss than males.
Trune DR; Kempton JB
Hear Res; 2002 May; 167(1-2):170-4. PubMed ID: 12117539
[TBL] [Abstract][Full Text] [Related]
14. Inner ear DNA receptors in MRL/lpr autoimmune mice: potential 30 and 70 kDa link between autoimmune disease and hearing loss.
Trune DR; Kempton JB; Hefeneider SH; Bennett RM
Hear Res; 1997 Mar; 105(1-2):57-64. PubMed ID: 9083804
[TBL] [Abstract][Full Text] [Related]
15. Decreased auditory function in the C3H/lpr autoimmune disease mouse.
Trune DR; Kempton JB; Mitchell C
Hear Res; 1996 May; 95(1-2):57-62. PubMed ID: 8793508
[TBL] [Abstract][Full Text] [Related]
16. Strial dysfunction in the MRL-Fas mouse.
Ruckenstein MJ; Milburn M; Hu L
Otolaryngol Head Neck Surg; 1999 Oct; 121(4):452-6. PubMed ID: 10504603
[TBL] [Abstract][Full Text] [Related]
17. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow cells as an origin of immune-mediated hearing loss.
Iwai H; Lee S; Baba S; Tomoda K; Inaba M; Ikehara S; Yamashita T
Acta Otolaryngol; 2004 Jan; 124(1):8-12. PubMed ID: 14977070
[TBL] [Abstract][Full Text] [Related]
20. MRL/MP-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss.
Kusakari C; Hozawa K; Koike S; Kyogoku M; Takasaka T
Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():82-6. PubMed ID: 1416659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
